Uwe Reuter: a leader in migraine

The Lancet Neurology · Published 2026-05-14 · DOI 10.1016/s1474-4422(26)00174-2

Authors (1)

Udani Samarasekera

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Samarasekera, U. (2026). Uwe Reuter: a leader in migraine. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(26)00174-2

Related articles

• The epidemiology of unruptured intracranial aneurysm in Finland – Authors’ reply · The Lancet Neurology · 2026 · Same journal
• Lifeline · The Lancet Neurology · 2026 · Same journal
• Virus-specific T-cell therapy for neuroinvasive West Nile virus · The Lancet Neurology · 2026 · Same journal
• Optic nerve involvement in multiple sclerosis diagnosis – Authors’ reply · The Lancet Neurology · 2026 · Same journal
• Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial · The Lancet Neurology · 2026 · Same journal
• Natural experiments on herpes zoster vaccines and dementia · The Lancet Neurology · 2026 · Same journal
• Diagnosis of exclusion versus no better explanation · The Lancet Neurology · 2026 · Same journal
• Building systems-based epilepsy surgery in sub-Saharan Africa · The Lancet Neurology · 2026 · Same journal
• UCL Queen Square Institute of Neurology: 75 years of innovation · The Lancet Neurology · 2026 · Same journal
• Safety and efficacy of staged, bilateral magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson's disease: a prospective, multicentre, single-arm trial · The Lancet Neurology · 2026 · Same journal